drugset / Trial / NCT03838094

Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars

NCT03838094

Phase 1/2 Completed 30 enrolled Gihan M Abuelniel ,PhD Cairo University · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Aim of the study: To compare the clinical and radiographic outcomes of mineral trioxide aggregate (MTA) and Biodentine as vital pulp therapy materials (pulpotomy) of cariously exposed vital immature mandibular first permanent molars. Materials and Methods: sixty immature first mandibular permanent molars cariously exposed with symptomatic /asymptomatic pulpitis were included in the study according to inclusion criteria and were equally divided in two groups. Following split-mouth design molars were randomly assigned to either a control group (MTA 30 molars) or a test group (Biodentine 30 molars). After conducting pulpotomy and covering pulp stumps with the MTA and Biodentine, treated molars received permanent restorations. Blinded clinical and radiographic evaluations were performed at different time intervals (base line immediate postoperative, 6, 12 and 18 months) according to clinical and radiographic criteria of success. Data were recorded and analysed.

Timeline

Start
2016-02
Primary completion
2018-08
Completion
2018-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Biodentine Other / unclassified
Comparator MTA Unknown

Indications